Immunovant, Inc. - 10-K Filing
Immunovant, Inc. filed its annual report on Form 10-K for the fiscal year ended March 31, 2026, providing a comprehensive overview of its financial condition and results of operations.
Tickers: $IMVT
More Regulatory news
- LiveOne, Inc. - 8-K Filing
- Solana Co - 10-Q Filing
- Solana Co - 8-K Filing
- DeFi Development Corp. - 8-K Filing
- Stablecoin Development Corp - 8-K Filing
- BCP Investment Corp - 8-K Filing
- OneWater Marine Inc. - 8-K Filing
- Moleculin Biotech, Inc. - 8-K Filing
- Investcorp Credit Management BDC, Inc. - 8-K Filing
- Presurance Holdings, Inc. - 10-Q Filing